<DOC>
	<DOCNO>NCT00214097</DOCNO>
	<brief_summary>The purpose study examine clinical feasibility use IMRT combine daily pretreatment prostate localization deliver increasingly hypofractionated treatment course . Progressively large fraction size deliver phase I design base acute long-term tolerance treatment . The dose-per-fraction escalation design utilizes schema maintain isoeffective dose late effect , predict tumor control actually improve . The delivery fewer , large fraction radiation , proven effective safe , would result significant cost save efficient use resource .</brief_summary>
	<brief_title>Phase I/II Hypofractionated Radiotherapy Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Prostate Cancer stage 2b less , predict risk lymph node involvement le 15 % , Gleason &lt; 7 , No distance mets distant mets</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>